Sabz Biomedicals   Report issue

For profit Phase 1 Phase 2
Founded: Tehran Iran (Islamic Republic of) (1998)
Status: No NME R&D (1998)

Organization Overview

First Clinical Trial
2018
NCT03329664
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Sabz Biomedicals